Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Public Health Manag Pract. 2017 May-Jun;23(3):283–290. doi: 10.1097/PHH.0000000000000440

Table 2.

Human Papillomavirus (HPV) Vaccination among Female Adolescents in Commercial and Medicaid Health Plans: Key Facilitators and Barriers

Facilitators Barriers

  • “Normalize” the vaccine - present it as part of a routine immunization schedule with other recommended adolescent vaccines and emphasize the health aspects of the vaccine (e.g. cancer prevention)

  • Educate patients and providers

  • Provide reminders to patients and providers

  • Increase care opportunities

  • Provide feedback to providers about their performance

  • Ensure widespread access to registry data

  • Vaccine refusal and stigma regarding sexual activity

  • Challenges in scheduling and administering the full three doses of the vaccine